You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
YPF Sociedad Anonima (YPF) - free report >>
ADMA Biologics Inc (ADMA) - free report >>
Ekso Bionics Holdings, Inc. (EKSO) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 31st
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
ADMA Biologics, Inc. (ADMA - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
ADMA Biologics Inc Price and Consensus
ADMA Biologics Inc price-consensus-chart | ADMA Biologics Inc Quote
Inhibikase Therapeutics, Inc. (IKT - Free Report) : This clinical-stage pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 16% over the last 60 days.
Inhibikase Therapeutics, Inc. Price and Consensus
Inhibikase Therapeutics, Inc. price-consensus-chart | Inhibikase Therapeutics, Inc. Quote
YPF Sociedad Anónima (YPF - Free Report) : This international energy company engaging in the integrated business of hydrocarbons has seen the Zacks Consensus Estimate for its current year earnings increasing 24.2% over the last 60 days.
YPF Sociedad Anonima Price and Consensus
YPF Sociedad Anonima price-consensus-chart | YPF Sociedad Anonima Quote
Anavex Life Sciences Corp. (AVXL - Free Report) : This clinical stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.
Anavex Life Sciences Corp. Price and Consensus
Anavex Life Sciences Corp. price-consensus-chart | Anavex Life Sciences Corp. Quote
Ekso Bionics Holdings, Inc. (EKSO - Free Report) : This exoskeleton products company has seen the Zacks Consensus Estimate for its current year earnings increasing 25.6% over the last 60 days.
Ekso Bionics Holdings, Inc. Price and Consensus
Ekso Bionics Holdings, Inc. price-consensus-chart | Ekso Bionics Holdings, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.